CM
HZNP

Caption Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Caption Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,143,800
Closed -$132M – 1792
2023
Q3 		$132M Sell
1,143,800
-24,900
-2% -$2.68M 2.04% 2
2023
Q2 		$120M Buy
1,168,700
+791,200
+210% +$83.5M 2.13% 2
2023
Q1 		$41.2M Sell
377,500
-743,500
-66% -$82.2M 0.8% 18
2022
Q4 		$128M Buy
1,121,000
+963,500
+612% +$80M 1.99% 2
2022
Q3 		$9.75M Buy
157,500
+152,500
+3,050% +$10.7M 0.13% 181
2022
Q2 		$399K Sell
5,000
-120,000
-96% -$11.4M 0.01% 1121
2022
Q1 		$13.2M Sell
125,000
-52,200
-29% -$5.09M 0.16% 151
2021
Q4 		$19.1M Sell
177,200
-145,700
-45% -$15.9M 0.21% 105
2021
Q3 		$35.4M Buy
322,900
+169,900
+111% +$17.6M 0.4% 39
2021
Q2 		$14.3M Sell
153,000
-234,700
-61% -$21.6M 0.19% 122
2021
Q1 		$35.7M Buy
387,700
+318,000
+456% +$26.8M 0.77% 15
2020
Q4 		$5.1M Sell
69,700
-30,300
-30% -$2.25M 0.12% 214
2020
Q3 		$7.77M Buy
+100,000
New +$6.88M 0.18% 130
2020
Q1 		– Sell
-10,000
Closed -$363K – 1245
2019
Q4 		$363K Hold
10,000
– – 0.01% 673
2019
Q3 		$272K Buy
+10,000
New +$259K 0.01% 559
2019
Q2 		– Sell
-171,400
Closed -$4.53M – 920
2019
Q1 		$4.53M Buy
+171,400
New +$4.06M 0.25% 122

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Caption Management's HZNP Position: Q4 2022 in Review

Caption Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2022, closing a stake of 61,380 shares — an estimated $5.1M sold.

Caption Management first reported a position in HZNP in Q3 2019 and held it in 9 quarters. The position peaked at $12.1M in Q1 2021. 615 funds tracked by Wall St. Rank hold HZNP as of Q4 2022.

  • Caption Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2022 after selling out during the quarter.
  • Caption Management sold 61,380 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2022, an estimated $5.1M.
  • Caption Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2019 and held it in 9 quarters.
  • Caption Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $12.1M in Q1 2021.
  • 615 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2022.

Based on Caption Management's 13F filing for Q4 2022, filed 14 Feb 2023.